The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro.
Open accessAbstract
The pharmacologic activities of leukotrienes C-1 and D(LTC-1 and LTD), constituents of slow reacting substance of anaphylaxis (SRS-A), were evaluated in vitro on airway contractile tissues and in vivo on pulmonary mechanical function, mean systemic arterial pressure, and cutaneous microcirculation. In vitro both LTC-1 and LTD were potent and selective peripheral airway agonists, being more active than histamine; furthermore, LTD was active on peripheral airways at concentrations 1/100th those of LTC-1. The concentration-effect relationship for LTD and the profile of antagonism by FPL 55712 are consistent with the activity of this molecule at two separate peripheral airway receptors. In vivo, LTC-1 and LTD were nearly equally active in their effects on pulmonary mechanics, and the pattern of alterations was consistent with the predominant site of action being in the lung periphery. Furthermore, both agents had a direct systemic arterial hypotensive effect and were vasoactive on the cutaneous microcirculation. Thus, these compounds are likely to be major mediators of the pathologic alterations in immediate type hypersensitivity reactions in which peripheral airway constriction and hypotension are prominent features.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SOME QUANTITATIVE USES OF DRUG ANTAGONISTS
ARUNLAKSHANA, O., & SCHILD, H. O. (1959) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1959.tb00928.x · Cited by 3,938
Leukotriene C: a slow-reacting substance from murine mastocytoma cells.
Murphy, R. C., Hammarström, S., & Samuelsson, B. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4275 · Cited by 991
Brocklehurst, W. E. (1960) · The Journal of Physiology · doi:10.1113/jphysiol.1960.sp006449 · Cited by 634
Mechanics of Respiration in Unanesthetized Guinea Pigs
Amdur, M. O., & Mead, J. (1958) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1958.192.2.364 · Cited by 632
Lewis, R. A., Austen, K. F., Drazen, J. M., Clark, D. A., Marfat, A., & Corey, E. J. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.6.3710 · Cited by 431
Self-citationStructure of leukotriene C identification of the amino acid part
Hammarström, S., Murphy, R. C., Samuelsson, B., Clark, D. A., Mioskowski, C., & Corey, E. J. (1979) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(79)91203-8 · Cited by 305
Self-citationCellular and Humoral Mechanisms in Anaphylaxis and Allergy.
(1970) · Annals of Internal Medicine · doi:10.7326/0003-4819-72-2-305_8 · Cited by 144
Cited by
Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation
Samuelsson, B. (1983) · Science · doi:10.1126/science.6301011 · Cited by 2,843
Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological Effects
Samuelsson, B., Dahlén, S.-E., Lindgren, J. Å., Rouzer, C. A., & Serhan, C. N. (1987) · Science · doi:10.1126/science.2820055 · Cited by 2,233
Lewis (1990) · doi:10.1056/nejm199009063231006 · Cited by 1,200
Dahlén, S. E., Björk, J., Hedqvist, P., Arfors, K. E., Hammarström, S., Lindgren, J. A., & Samuelsson, B. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.6.3887 · Cited by 1,019
Treatment of Asthma with Drugs Modifying the Leukotriene Pathway
Drazen, J. M., Israel, E., & O'Byrne, P. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901213400306 · Cited by 820
Self-citationLewis, R. A., & Austen, K. F. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111312 · Cited by 656
Self-citationGalli, S. J. (2000) · Current Opinion in Hematology · doi:10.1097/00062752-200001000-00007 · Cited by 521
Lewis, R. A., & Austen, K. F. (1981) · Nature · doi:10.1038/293103a0 · Cited by 473
Self-citationDahlén, S. E., Hansson, G., Hedqvist, P., Björck, T., Granström, E., & Dahlén, B. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.6.1712 · Cited by 415
Bronchoconstrictor Effects of Leukotriene C in Humans
Weiss, J. W., Drazen, J. M., Coles, N., McFadden, E. R., Weller, P. F., Corey, E. J., Lewis, R. A., & Austen, K. F. (1982) · Science · doi:10.1126/science.7063880 · Cited by 406
Self-citationPeptide Leukotriene Release after Antigen Challenge in Patients Sensitive to Ragweed
Creticos, P. S., Peters, S. P., Adkinson, N. F., Naclerio, R. M., Hayes, E. C., Norman, P. S., & Lichtenstein, L. M. (1984) · New England Journal of Medicine · doi:10.1056/nejm198406213102502 · Cited by 394
Israel, E., Fischer, A. R., Rosenberg, M. A., Lilly, C. M., Callery, J. C., Shapiro, J., Cohn, J., Rubin, P., & Drazen, J. M. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.6_pt_1.1447 · Cited by 377
Self-citationPollart, S. M., Chapman, M. D., Fiocco, G. P., Rose, G., & Platts-Mills, T. A. E. (1989) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(89)90100-0 · Cited by 341
Leukotriene modifiers as potential therapeutics for cardiovascular disease
Funk, C. D. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1796 · Cited by 326
The importance of leukotrienes in airway inflammation in a mouse model of asthma.
Henderson, W. R., Lewis, D. B., Albert, R. K., Zhang, Y., Lamm, W. J., Chiang, G. K., Jones, F., Eriksen, P., Tien, Y. T., Jonas, M., et al. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.4.1483 · Cited by 311
Barnes, N. C., Piper, P. J., & Costello, J. F. (1984) · Thorax · doi:10.1136/thx.39.7.500 · Cited by 304
Leukotrienes and Airway Responses
Drazen, J. M., & Austen, K. F. (1987) · American Review of Respiratory Disease · doi:10.1164/ajrccm/136.4.985 · Cited by 293
Self-citationInternational Union of Pharmacology XXXVII. Nomenclature for Leukotriene and Lipoxin Receptors
Brink, C., Dahlén, S.-E., Drazen, J., Evans, J. F., Hay, D. W. P., Nicosia, S., Serhan, C. N., Shimizu, T., & Yokomizo, T. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.8 · Cited by 286
Self-citationPharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist
Jones, T. R., Zamboni, R., Belley, M., Champion, E., Charette, L., Ford-Hutchinson, A. W., Frenette, R., Gauthier, J.-Y., Leger, S., Masson, P., et al. (1989) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y89-004 · Cited by 270
Leukotriene B4 action on endothelium mediates augmented neutrophil/endothelial adhesion.
Hoover, R. L., Karnovsky, M. J., Austen, K. F., Corey, E. J., & Lewis, R. A. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.7.2191 · Cited by 256
Self-citationRelease of leukotriene C4 in respiratory tract during acute viral infection
Volovitz, B., Faden, H., & Ogra, P. L. (1988) · The Journal of Pediatrics · doi:10.1016/s0022-3476(88)80058-1 · Cited by 102
Metadata
- Authors
- Drazen, J. M., Austen, K. F., Lewis, R. A., Clark, D. A., Goto, G., Marfat, A., & Corey, E. J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1980-07
- Volume
- 77
- Issue
- 7
- Pages
- 4354-4358
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2046679315
- Cited by
- 626
- References
- 7
- FWCI
- 48.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.